The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database
Open accessAbstract
BACKGROUND: The primary aim was to use routine data to compare cancer diagnostic intervals before and after implementation of the 2005 NICE Referral Guidelines for Suspected Cancer. The secondary aim was to compare change in diagnostic intervals across different categories of presenting symptoms. METHODS: Using data from the General Practice Research Database, we analysed patients with one of 15 cancers diagnosed in either 2001-2002 or 2007-2008. Putative symptom lists for each cancer were classified into whether or not they qualified for urgent referral under NICE guidelines. Diagnostic interval (duration from first presented symptom to date of diagnosis in primary care records) was compared between the two cohorts. RESULTS: In total, 37,588 patients had a new diagnosis of cancer and of these 20,535 (54.6%) had a recorded symptom in the year prior to diagnosis and were included in the analysis. The overall mean diagnostic interval fell by 5.4 days (95% CI: 2.4-8.5; P<0.001) between 2001-2002 and 2007-2008. There was evidence of significant reductions for the following cancers: (mean, 95% confidence interval) kidney (20.4 days, -0.5 to 41.5; P=0.05), head and neck (21.2 days, 0.2-41.6; P=0.04), bladder (16.4 days, 6.6-26.5; P≤0.001), colorectal (9.0 days, 3.2-14.8; P=0.002), oesophageal (13.1 days, 3.0-24.1; P=0.006) and pancreatic (12.6 days, 0.2-24.6; P=0.04). Patients who presented with NICE-qualifying symptoms had shorter diagnostic intervals than those who did not (all cancers in both cohorts). For the 2007-2008 cohort, the cancers with the shortest median diagnostic intervals were breast (26 days) and testicular (44 days); the highest were myeloma (156 days) and lung (112 days). The values for the 90th centiles of the distributions remain very high for some cancers. Tests of interaction provided little evidence of differences in change in mean diagnostic intervals between those who did and did not present with symptoms specifically cited in the NICE Guideline as requiring urgent referral. CONCLUSION: We suggest that the implementation of the 2005 NICE Guidelines may have contributed to this reduction in diagnostic intervals between 2001-2002 and 2007-2008. There remains considerable scope to achieve more timely cancer diagnosis, with the ultimate aim of improving cancer outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bootstrap Methods and their Application
Davison, A. C., & Hinkley, D. V. (1997) · doi:10.1017/cbo9780511802843 · Cited by 7,350
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109 · cited 10×
“…high-quality, and validated UK general practice data set, that has previously been used for cancer diagnostic studies (Jones et al, 2007; Dommett et al, 2012); and recent systematic reviews have confirmed the validity of diagnostic coding within GPRD (Herrett et al, 2010; Khan et al, 2010).”
BackgroundMethodInfluentialHow should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772 · cited 1×
“Therefore, the mean and standard deviation for each cohort are also shown (Thompson and Barber, 2000).”
MethodLyratzopoulos, G., Neal, R. D., Barbiere, J. M., Rubin, G. P., & Abel, G. A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70041-4 · Cited by 425 · cited 1×
“It can complement recent insights into the number of GP consultations prior to referral to provide a more complete picture of the diagnostic process (Lyratzopoulos et al, 2012).”
BackgroundSelf-citationWhat if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman, M., Stockton, D., Rachet, B., Hakulinen, T., & Coleman, M. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605401 · Cited by 160 · cited 2×
“…5 years of diagnosis could be avoided annually in England if efforts to promote earlier diagnosis and appropriate primary surgical treatment are successful (Abdel-Rahman et al, 2009) and a National Awareness and Early Diagnosis Initiative (NAEDI) is addressing this challenge (Richards, 2009).”
Background
Cited by
Pourshams, A., Sepanlou, S. G., Ikuta, K. S., Bisignano, C., Safiri, S., Roshandel, G., Sharif, M., Khatibian, M., Fitzmaurice, C., Nixon, M. R., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30347-4 · Cited by 658
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016
Cowan, A. J., Allen, C., Barac, A., Basaleem, H., Bensenor, I., Curado, M. P., Foreman, K., Gupta, R., Harvey, J., Hosgood, H. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2128 · Cited by 631
Kamangar, F., Nasrollahzadeh, D., Safiri, S., Sepanlou, S. G., Fitzmaurice, C., Ikuta, K. S., Bisignano, C., Islami, F., Roshandel, G., Lim, S. S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30007-8 · Cited by 641
Etemadi, A., Safiri, S., Sepanlou, S. G., Ikuta, K., Bisignano, C., Shakeri, R., Amani, M., Fitzmaurice, C., Nixon, M., Abbasi, N., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30328-0 · Cited by 635
The expanding role of primary care in cancer control
Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00205-3 · Cited by 555
Self-citationColorectal liver metastases: Current management and future perspectives
Martin, J., Petrillo, A., Smyth, E. C., Shaida, N., Khwaja, S., Cheow, H., Duckworth, A., Heister, P., Praseedom, R., Jah, A., et al. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i10.761 · Cited by 275
Walter, F. M., Mills, K., Mendonça, S. C., Abel, G. A., Basu, B., Carroll, N., Ballard, S., Lancaster, J., Hamilton, W., Rubin, G. P., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30079-6 · Cited by 174
Self-citationPearson, C., Poirier, V., Fitzgerald, K., Rubin, G., & Hamilton, W. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033008 · Cited by 49
Self-citationArhi, C. S., Burns, E. M., Bottle, A., Bouras, G., Aylin, P., Ziprin, P., & Darzi, A. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x710441 · Cited by 33
Metadata
- Authors
- Neal, R. D., Din, N. U., Hamilton, W., Ukoumunne, O. C., Carter, B., Stapley, S., & Rubin, G.
- Venue
- British Journal of Cancer
- Published
- 2013-12-24
- Volume
- 110
- Issue
- 3
- Pages
- 584-592
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1975388565
- Cited by
- 212
- References
- 5
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.